Cite
HARVARD Citation
Allegretti, J. et al. (n.d.). S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection. American journal of gastroenterology. p. S63. [Online].